임상시험 아웃소싱 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2035년)
Clinical Trials Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
상품코드:1721211
리서치사:Transparency Market Research
발행일:2025년 03월
페이지 정보:영문 213 Pages
라이선스 & 가격 (부가세 별도)
한글목차
임상시험 아웃소싱 시장 : 조사 범위
TMR의 "세계 임상시험 아웃소싱 시장" 보고서는 2025-2035년의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2019년부터 2035년까지의 세계 임상시험 아웃소싱 시장의 수익과 예측을 제공하고자 2025년을 기준 연도로, 2035년을 예측 연도로 삼고 있습니다. 또한, 2025-2035년 세계 임상시험 아웃소싱 시장의 CAGR(연평균 성장률)을 제시합니다.
본 보고서는 광범위한 1차 조사, KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도자료, 관련 자료, 임상시험 등을 통해 아웃소싱 시장을 추론했습니다. 임상시험 아웃소싱 시장을 추론하였습니다.
시장 현황
2024년 시장 규모
507억 달러
2035년 시장 규모
1,019억 달러
CAGR
6.4%
이 보고서는 세계 임상시험 아웃소싱 시장의 경쟁 환경을 조사했습니다. 세계 임상시험 아웃소싱 시장에서 활동하는 주요 업체를 파악하고, 각 업체는 다양한 속성별로 프로파일링되어 있습니다. 기업 개요, 재무 상태, 최근 동향, SWOT 등 세계 임상시험 아웃소싱 시장의 기업 속성은 본 보고서에서 소개됩니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계의 임상시험 아웃소싱 시장 분석과 예측(2020년-2035년)
제5장 주요 인사이트
주요 업계 이벤트
영향 분석
PESTEL 분석
주요 국가, 지역별 규제 시나리오
Porter의 Five Forces 분석
기술적 진보
자금조달/투자 시나리오
제6장 세계 시장 분석 및 예측 : 서비스 유형별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 서비스 유형별(2020년-2035년)
실험실 서비스
생체 분석 시험 서비스
분산형 임상시험 서비스
환자 모집
사이트 식별
분석 시험 서비스
임상시험 공급 및 물류 서비스
프로토콜 설계
임상시험 데이터 관리 서비스
의료기기 시험 서비스
기타
시장의 매력 분석 : 서비스 유형별
제7장 세계 시장 분석 및 예측 : 치료 영역별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 치료 영역별(2020년-2035년)
종양학
감염증
신경학
대사장애
면역학
심장병학
유전성 질환
여성 건강
기타
시장의 매력 분석 : 치료 영역별
제8장 세계 시장 분석 및 예측 : 용도별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 용도별(2020년-2035년)
소분자
단일클론항체
백신
세포 및 유전자 치료
기타
시장의 매력 분석 : 용도별
제9장 세계 시장 분석 및 예측 : 최종사용자별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 최종사용자별(2020년-2035년)
제약 및 바이오테크놀러지 기업
의료기기 제조업체
시장의 매력 분석 : 최종사용자별
제10장 세계 시장 분석 및 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별(2020년-2035년)
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 기업 : 경쟁 매트릭스(기업 Tier별, 규모별)
시장 점유율 분석 : 기업별(2024년)
기업 개요
ICON plc
IQVIA
Thermo Fisher Scientific Inc.
SGS Life Sciences
Charles River Laboratories
Parexel
Syneos Health
Medpace
LabCorp
KCR
PRA Health Sciences
WuXi AppTec
Pharmaron
Avance Clinical
Pharmaron
LSH
영문 목차
영문목차
Clinical Trials Outsourcing Market - Scope of Report
TMR's report on the global clinical trials outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global clinical trials outsourcing market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global clinical trials outsourcing market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the clinical trials outsourcing market.
Market Snapshot
Market Value in 2024
US$ 50.7 Bn
Market Value in 2035
US$ 101.9 Bn
CAGR
6.4%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global clinical trials outsourcing market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global clinical trials outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global clinical trials outsourcing market.
The report delves into the competitive landscape of the global clinical trials outsourcing market. Key players operating in the global clinical trials outsourcing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global clinical trials outsourcing market profiled in this report.
Key Questions Answered in Global clinical trials outsourcing market Report:
What is the sales/revenue generated by clinical trials outsourcing across all regions during the forecast period?
What are the opportunities in the global clinical trials outsourcing market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Clinical Trials Outsourcing Market - Research Objectives and Research Approach
The comprehensive report on the global clinical trials outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global clinical trials outsourcing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global clinical trials outsourcing market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Clinical Trials Outsourcing Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Clinical Trials Outsourcing Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Impact Analysis
5.3. PESTEL Analysis
5.4. Regulatory Scenario by Key Countries/Regions
5.5. PORTER's Five Forces Analysis
5.6. Technological Advancements
5.7. Fund Raise/Investment Scenario
6. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Service Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Service Type, 2020-2035
6.3.1. Laboratory Services
6.3.2. Bioanalytical Testing Services
6.3.3. Decentralized Clinical Trial Services
6.3.4. Patient Recruitment
6.3.5. Site Identification
6.3.6. Analytical Testing Services
6.3.7. Clinical Trial Supply & Logistic Services
6.3.8. Protocol Designing
6.3.9. Clinical Trial Data Management Services
6.3.10. Medical Device Testing Services
6.3.11. Others
6.4. Market Attractiveness Analysis, by Service Type
7. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Therapeutic Area
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Therapeutic Area, 2020-2035
7.3.1. Oncology
7.3.2. Infectious Diseases
7.3.3. Neurology
7.3.4. Metabolic Disorders
7.3.5. Immunology
7.3.6. Cardiology
7.3.7. Genetic Diseases
7.3.8. Women's Health
7.3.9. Others
7.4. Market Attractiveness Analysis, by Therapeutic Area
8. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2035
8.3.1. Small Molecules
8.3.2. Monoclonal Antibodies
8.3.3. Vaccine
8.3.4. Cell & Gene Therapy
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Clinical Trials Outsourcing Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2035
9.3.1. Pharmaceutical and Biotech Companies
9.3.2. Medical Device Manufacturers
9.4. Market Attractiveness Analysis, by End-user
10. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2035
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region
11. North America Clinical Trials Outsourcing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Service Type, 2020-2035
11.2.1. Laboratory Services
11.2.2. Bioanalytical Testing Services
11.2.3. Decentralized Clinical Trial Services
11.2.4. Patient Recruitment
11.2.5. Site Identification
11.2.6. Analytical Testing Services
11.2.7. Clinical Trial Supply & Logistic Services
11.2.8. Protocol Designing
11.2.9. Clinical Trial Data Management Services
11.2.10. Medical Device Testing Services
11.2.11. Others
11.3. Market Value Forecast, by Therapeutic Area, 2020-2035
11.3.1. Oncology
11.3.2. Infectious Diseases
11.3.3. Neurology
11.3.4. Metabolic Disorders
11.3.5. Immunology
11.3.6. Cardiology
11.3.7. Genetic Diseases
11.3.8. Women's Health
11.3.9. Others
11.4. Market Value Forecast, by Application, 2020-2035
11.4.1. Small Molecules
11.4.2. Monoclonal Antibodies
11.4.3. Vaccine
11.4.4. Cell & Gene Therapy
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2020-2035
11.5.1. Pharmaceutical and Biotech Companies
11.5.2. Medical Device Manufacturers
11.6. Market Value Forecast, by Country, 2020-2035
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Service Type
11.7.2. By Therapeutic Area
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Clinical Trials Outsourcing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Service Type, 2020-2035
12.2.1. Laboratory Services
12.2.2. Bioanalytical Testing Services
12.2.3. Decentralized Clinical Trial Services
12.2.4. Patient Recruitment
12.2.5. Site Identification
12.2.6. Analytical Testing Services
12.2.7. Clinical Trial Supply & Logistic Services
12.2.8. Protocol Designing
12.2.9. Clinical Trial Data Management Services
12.2.10. Medical Device Testing Services
12.2.11. Others
12.3. Market Value Forecast, by Therapeutic Area, 2020-2035
12.3.1. Oncology
12.3.2. Infectious Diseases
12.3.3. Neurology
12.3.4. Metabolic Disorders
12.3.5. Immunology
12.3.6. Cardiology
12.3.7. Genetic Diseases
12.3.8. Women's Health
12.3.9. Others
12.4. Market Value Forecast, by Application, 2020-2035
12.4.1. Small Molecules
12.4.2. Monoclonal Antibodies
12.4.3. Vaccine
12.4.4. Cell & Gene Therapy
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2020-2035
12.5.1. Pharmaceutical and Biotech Companies
12.5.2. Medical Device Manufacturers
12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Service Type
12.7.2. By Therapeutic Area
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Clinical Trials Outsourcing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Service Type, 2020-2035
13.2.1. Laboratory Services
13.2.2. Bioanalytical Testing Services
13.2.3. Decentralized Clinical Trial Services
13.2.4. Patient Recruitment
13.2.5. Site Identification
13.2.6. Analytical Testing Services
13.2.7. Clinical Trial Supply & Logistic Services
13.2.8. Protocol Designing
13.2.9. Clinical Trial Data Management Services
13.2.10. Medical Device Testing Services
13.2.11. Others
13.3. Market Value Forecast, by Therapeutic Area, 2020-2035
13.3.1. Oncology
13.3.2. Infectious Diseases
13.3.3. Neurology
13.3.4. Metabolic Disorders
13.3.5. Immunology
13.3.6. Cardiology
13.3.7. Genetic Diseases
13.3.8. Women's Health
13.3.9. Others
13.4. Market Value Forecast, by Application, 2020-2035
13.4.1. Small Molecules
13.4.2. Monoclonal Antibodies
13.4.3. Vaccine
13.4.4. Cell & Gene Therapy
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2020-2035
13.5.1. Pharmaceutical and Biotech Companies
13.5.2. Medical Device Manufacturers
13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Service Type
13.7.2. By Therapeutic Area
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Clinical Trials Outsourcing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Service Type, 2020-2035
14.2.1. Laboratory Services
14.2.2. Bioanalytical Testing Services
14.2.3. Decentralized Clinical Trial Services
14.2.4. Patient Recruitment
14.2.5. Site Identification
14.2.6. Analytical Testing Services
14.2.7. Clinical Trial Supply & Logistic Services
14.2.8. Protocol Designing
14.2.9. Clinical Trial Data Management Services
14.2.10. Medical Device Testing Services
14.2.11. Others
14.3. Market Value Forecast, by Therapeutic Area, 2020-2035
14.3.1. Oncology
14.3.2. Infectious Diseases
14.3.3. Neurology
14.3.4. Metabolic Disorders
14.3.5. Immunology
14.3.6. Cardiology
14.3.7. Genetic Diseases
14.3.8. Women's Health
14.3.9. Others
14.4. Market Value Forecast, by Application, 2020-2035
14.4.1. Small Molecules
14.4.2. Monoclonal Antibodies
14.4.3. Vaccine
14.4.4. Cell & Gene Therapy
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2020-2035
14.5.1. Pharmaceutical and Biotech Companies
14.5.2. Medical Device Manufacturers
14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Service Type
14.7.2. By Therapeutic Area
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Clinical Trials Outsourcing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Service Type, 2020-2035
15.2.1. Laboratory Services
15.2.2. Bioanalytical Testing Services
15.2.3. Decentralized Clinical Trial Services
15.2.4. Patient Recruitment
15.2.5. Site Identification
15.2.6. Analytical Testing Services
15.2.7. Clinical Trial Supply & Logistic Services
15.2.8. Protocol Designing
15.2.9. Clinical Trial Data Management Services
15.2.10. Medical Device Testing Services
15.2.11. Others
15.3. Market Value Forecast, by Therapeutic Area, 2020-2035
15.3.1. Oncology
15.3.2. Infectious Diseases
15.3.3. Neurology
15.3.4. Metabolic Disorders
15.3.5. Immunology
15.3.6. Cardiology
15.3.7. Genetic Diseases
15.3.8. Women's Health
15.3.9. Others
15.4. Market Value Forecast, by Application, 2020-2035
15.4.1. Small Molecules
15.4.2. Monoclonal Antibodies
15.4.3. Vaccine
15.4.4. Cell & Gene Therapy
15.4.5. Others
15.5. Market Value Forecast, by End-user, 2020-2035
15.5.1. Pharmaceutical and Biotech Companies
15.5.2. Medical Device Manufacturers
15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Service Type
15.7.2. By Therapeutic Area
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
